Business
Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents
(TheNewswire) Calgary, Alberta, Canada – TheNewswire - June 4, 2025 - Voyage...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta, Canada –\n \n\n TheNewswire -\n \n\n June 4, 2025 - Voyageur\nPharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (\"Voyageur\"\nor the \"Company\"), a radiology contrast media company\nfocused on vertical integration and supply chain security, today\nannounced its first commercial sale, marking the Company’s official\nentry into revenue generating operations. The initial C$89,000\npurchase order, placed by a leading Canadian radiology provider,\nincludes the full suite of Voyageur’s Health Canada–approved\nbarium contrast products.\n \n\n\n\n The order follows successful product evaluations and\nregulatory milestones, with first deliveries scheduled to begin in\nAugust through the Company’s Calgary-based manufacturing partner.\n \n\n\n\n “This sale marks the beginning of Voyageur’s\ncommercial era,” said Brent Willis, President and CEO. “It\nconfirms market demand for our domestically produced contrast agents\nand sets the stage for accelerated revenue growth as we scale\noperations and distribution “\n \n\n\n\n Approved Product Line Now\nCommercialized\n \n\n :\n \n\n\n\n Voyageur’s approved barium contrast agents are\noptimized for a range of gastrointestinal imaging applications:\n \n\n\n\n\n\n SmoothX (2%w/v):\n \n\n For CT imaging of the GI tract; noted for its improved taste\nand tolerability.\n \n\n\n\n\n\n SmoothHD® 105%:\n \n\n High-density suspension for upper GI and double contrast\nstudies; delivering sharp mucosal detail.\n \n\n\n\n\n\n\n\n SmoothLD®\n \n\n (60%\nw/v):\n \n\n Low-density suspension for single contrast\nGI studies.\n \n\n\n\n\n\n\n\n VisionHD®\n \n\n (98%\nw/w):\n \n\n Powdered high-density suspension for upper\nGI double-contrast imaging.\n \n\n\n\n\n\n\n\n VisionLD®\n \n\n (96%\nw/w):\n \n\n Powdered low-density suspension for single\ncontrast studies.\n \n\n\n\n\n\n Poised for Scalable Growth with\nStrategic Resource Advantage\n \n\n\n\n With commercial sales now underway, Voyageur is focused\non expanding distribution across Canada. This infrastructure is\ndesigned to scale alongside the Company’s Frances Creek Pr...